Workflow
步长制药:控股子公司步长药妆股权调整完成公司持股比例提升至94.5%

Group 1 - The company acquired 1.50% of unfulfilled equity in Buchang Pharmaceutical's subsidiary, Buchang Cosmetics, from Zhao Lu for 0 yuan, while Zhao Lu transferred the remaining equity: 1.00% to Xie Jihui and 0.50% to Wang Qi, also for 0 yuan [2] - Before the transaction, the shareholding structure was: Buchang Pharmaceutical 94.00%, Chen Gongming 3.00%, Zhao Lu 3.00%. After the transaction, the structure changed to: Buchang Pharmaceutical 94.50%, Chen Gongming 3.00%, Xie Jihui 2.00%, Wang Qi 0.50% [2] - Buchang Cosmetics was established in May 2024 with a registered capital of 10 million yuan. As of the first half of 2025, it reported a net asset of -45,100 yuan, revenue of 0 yuan, and a net profit of -29,300 yuan [2] Group 2 - The transaction does not constitute a related party transaction or a major asset restructuring [2] - The transaction does not change the scope of consolidation in the financial statements [2] - There is no significant adverse impact on the company's financial condition and operating results [2]